In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
Edesa Biotech Inc (NASDAQ: EDSA) closed the day trading at $1.3 down -6.47% from the previous closing price of $1.39. In other words, the price has decreased by -$6.47 from its previous closing price. On the day, 66798.0 shares were traded. EDSA stock price reached its highest trading level at $1.415 during the session, while it also had its lowest trading level at $1.275.
Ratios:
For a better understanding of EDSA, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.67 and its Current Ratio is at 10.67. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EDSA now has a Market Capitalization of 10833970 and an Enterprise Value of 9301994.
Stock Price History:
The Beta on a monthly basis for EDSA is 0.12, which has changed by -0.23204422 over the last 52 weeks, in comparison to a change of 0.14446163 over the same period for the S&P500. Over the past 52 weeks, EDSA has reached a high of $4.49, while it has fallen to a 52-week low of $1.38. The 50-Day Moving Average of the stock is -30.17%, while the 200-Day Moving Average is calculated to be -40.07%.
Shares Statistics:
Over the past 3-months, EDSA traded about 338.68K shares per day on average, while over the past 10 days, EDSA traded about 36110 shares per day. A total of 7.14M shares are outstanding, with a floating share count of 6.62M. Insiders hold about 20.61% of the company’s shares, while institutions hold 34.52% stake in the company. Shares short for EDSA as of 1764288000 were 51065 with a Short Ratio of 0.10, compared to 1761868800 on 127522. Therefore, it implies a Short% of Shares Outstanding of 51065 and a Short% of Float of 0.8099999999999999.
Earnings Estimates
The dynamic stock of Edesa Biotech Inc (EDSA) is currently being evaluated by a team of 3.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is -$0.45, with high estimates of -$0.24 and low estimates of -$0.82.
Analysts are recommending an EPS of between -$0.94 and -$3.26 for the fiscal current year, implying an average EPS of -$1.79. EPS for the following year is -$1.84, with 2.0 analysts recommending between -$0.69 and -$2.99.
